No abstract available
Keywords:
Ruxolitinib; Tocilizumab; cytokine storm; secondary haemophagocytic lymphohistiocytosis; severe COVID.
MeSH terms
-
Aged
-
Antibodies, Monoclonal, Humanized / administration & dosage*
-
COVID-19 Drug Treatment*
-
COVID-19* / blood
-
COVID-19* / complications
-
COVID-19* / diagnostic imaging
-
Drug Therapy, Combination
-
Female
-
Humans
-
Interleukin-6 / antagonists & inhibitors*
-
Janus Kinases / antagonists & inhibitors*
-
Lymphohistiocytosis, Hemophagocytic* / blood
-
Lymphohistiocytosis, Hemophagocytic* / diagnostic imaging
-
Lymphohistiocytosis, Hemophagocytic* / drug therapy
-
Lymphohistiocytosis, Hemophagocytic* / etiology
-
Male
-
Middle Aged
-
Nitriles
-
Pyrazoles / administration & dosage*
-
Pyrimidines
-
SARS-CoV-2*
-
STAT Transcription Factors / analysis*
Substances
-
Antibodies, Monoclonal, Humanized
-
IL6 protein, human
-
Interleukin-6
-
Nitriles
-
Pyrazoles
-
Pyrimidines
-
STAT Transcription Factors
-
ruxolitinib
-
Janus Kinases
-
tocilizumab